Eslava GJ

Language: Spanish
References: 14
Page: 310-310
PDF size: 85.17 Kb.

Text Extraction

No abstract.

REFERENCES

1. Tomasini C y Pippione M, Interstitial granulomatous dermatitis with plaques, J Am Acad Dermatol 2002; 46:892-9.

2. Hawryluk EB, Izikson L y English JC, Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence- based update to important clinical questions, Am J Clin Dermatol 2010; 11(3):171-81.

3. Johnson H, Mengden S y Brancaccio RR, Interstitial granulomatous dermatitis, Dermatol Online 2008; 14(5):18.

4. Magro CM, Crowson AN y Schapiro BL, The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity, J Cutan Pathol 1998; 25:72- 8.

5. Saha M, Gibbon KL, Jawad AS, Cerio R y Jolliffe VM, An unusual cause of cutaneous ulceration in association with seronegative rheumatoid arthritis, jrsm Sh Rep 2012; 3:54.

6. Wick MR, Granulomatous & histiocytic dermatitides, Semin Diagn Pathol 2017; 34(3):301-11.

7. Sayah A y English JC, Rheumatoid arthritis: a review of the cutaneous manifestations, J Am Acad Dermatol 2005; 53(2):191-209.

8. Arévalo M, Moreno M y Gratacós J, Dermatitis intersticial granulomatosa asociada al lupus: a propósito de un caso, Reumatología Clínica 2017; 13(6):367-8.

9. Krauter A, Gambichler T y Altmeyer P, Infliximab therapy for interstitial granulomatous dermatitis, J Eur Acad Dermatol Venereol 2007; 21:251-2.

10. Ahmed ZS, Joad S, Singh M y Bandagi SS, Interstitial granulomatous dermatitis successfully treated with etanercept, Am J Case Rep 2014; 15:94-6.

11. Schanz S, Schmatzung M, Guenova E, Metzler G, Ulmar A, Kötter I et al., Interstitial granulomatous dermatitis with arthritis responding to tocilizumab, Arch Dermatol 2012; 148:17-22.

12. Leloup P, Aubert H, Causse S, LeGoff B y Barbarot S, Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis, jama Dermatol 2013; 149:626-7.

13. Alghamdi R, Bejar C, Steff M, Deschamps L, Marinho E, Crickx B et al., Intravenous immunoglobulins as a treatment of interstitial granulomatous dermatitis with arthritis, Br J Dermatol 2012; 167V:218-20.

14. Collins CE, Dall’Era M, Kan H, Macahilig C, Molta C, Koscielny V et al., Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the observe study in the USA, Lupus Sci Med 2016; 3.